Wealth Management Associates, Inc. Exact Sciences Corp Transaction History

Wealth Management Associates, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 28, 2025	BUY	$65.94 - $99.04 $21,694 - $32,584	329 Added 4.72%	7,300 $498 Million
Q2 2023 May 28, 2025	SELL	$62.68 - $95.05 $15,795 - $23,952	-252 Reduced 3.49%	6,971 $655 Million
Q4 2022 May 28, 2025	SELL	$30.35 - $53.15 $24,128 - $42,254	-795 Reduced 9.92%	7,223 $358 Million
Q4 2021 May 28, 2025	BUY	$72.5 - $100.68 $26,825 - $37,251	370 Added 4.84%	8,018 $624 Million
Q3 2021 May 28, 2025	BUY	$90.24 - $124.05 $66,326 - $91,176	735 Added 10.63%	7,648 $730 Million

Q1 2021 May 28, 2025	SELL	$116.57 - $155.01 $25,062 - $33,327	-215 Reduced 3.02%	6,913 $911 Million
Q4 2020 May 28, 2025	SELL	$99.61 - $142.12 $89,649 - $127,908	-900 Reduced 11.21%	7,128 $944 Million
Q3 2020 May 28, 2025	BUY	$72.92 - $102.01 $10,354 - $14,485	142 Added 1.8%	8,028 $818 Million
Q2 2020 May 28, 2025	SELL	$55.75 - $92.75 $41,812 - $69,562	-750 Reduced 8.68%	7,886 $686 Million
Q1 2020 May 28, 2025	BUY	$37.9 - $104.44 $15,539 - $42,820	410 Added 4.98%	8,636 $501 Million
Q4 2019 May 28, 2025	BUY	$77.66 - $99.74 $38,830 - $49,870	500 Added 6.47%	8,226 $761 Million
Q3 2019 May 28, 2025	BUY	$90.37 - $122.49 $165,919 - $224,891	1,836 Added 31.17%	7,726 $698 Million
Q2 2019 May 28, 2025	SELL	$89.51 - $118.04 $35,804 - $47,216	-400 Reduced 6.36%	5,890 $695 Million
Q1 2019 May 28, 2025	SELL	$61.98 - $96.5 $55,782 - $86,850	-900 Reduced 12.52%	6,290 $545 Million
Q4 2018 May 28, 2025	BUY	$56.04 - $82.66 $402,927 - $594,325	7,190 New	7,190 $454 Million

687

161M

2.12M

1.69M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.9B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Wealth Management Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Wealth Management Associates, Inc. with notifications on news.